Prediction tests for recurrent hypertensive disease in pregnancy, a systematic review

Hypertension in Pregnancy

Volumn 29, Issue 2, 2010, Pages 206-230

  Sep, Simone ^a,b   Smits, Luc ^b   Prins, Martin ^b   Peeters, Louis ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

HELLP; Prediction; Preeclampsia; Pregnancy induced hypertension; Recurrence

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; THROMBOXANE B2;

ARTERY COMPLIANCE; ARTICLE; BLOOD CLOTTING; BLOOD FLOW VELOCITY; CAROTID ARTERY; CONFIDENCE INTERVAL; DIASTOLIC BLOOD PRESSURE; DOPPLER FLOWMETRY; ECLAMPSIA; EMBASE; ENDOTHELIUM CELL; EXTREMELY LOW BIRTH WEIGHT; FEMORAL ARTERY; FETUS OUTCOME; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; IMMUNE SYSTEM; INTRAUTERINE GROWTH RETARDATION; KIDNEY DISEASE; LABORATORY TEST; LOW BIRTH WEIGHT; MATERNAL AGE; MATERNAL HYPERTENSION; MEDLINE; OBESITY; PLASMA VOLUME; PREDICTION; PREDICTOR VARIABLE; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANCY TOXEMIA; PROTEINURIA; RECURRENT DISEASE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; THROMBOPHILIA; UTERINE ARTERY; UTERUS BLOOD FLOW; VASCULAR RESISTANCE; VERY LOW BIRTH WEIGHT; WEIGHT GAIN;

ANTHROPOMETRY; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MATERNAL BEHAVIOR; PLACENTAL CIRCULATION; PREDICTIVE VALUE OF TESTS; PREGNANCY; RECURRENCE; REPRODUCTIVE HISTORY; VASCULAR RESISTANCE;

EID: 77950812724     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950902968668     Document Type: Article

References (49)

1. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367(9516):1066-1074.
2. Report of the National High Blood Pressure Education Program. Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
3. Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004; 104(6): 1367-1391. (Pubitemid 40458737)
4. Engelhard IM, van Rij M, Boullart I, Ekhart TH, Spaanderman ME, van den Hout MA, et al. Posttraumatic stress disorder after pre-eclampsia: an exploratory study. Gen Hosp Psychiatry 2002; 24(4):260-264. (Pubitemid 34718153)
5. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282(11):1061-1066. (Pubitemid 29436454)
6. Deville WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2002; 2: 9. (Pubitemid 38994353)
7. Whiting P, Rutjes A, Reitsma J, Bossuyt P, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3(1):25. (Pubitemid 38789561)
8. Cnossen JS, van der Post JA, Mol BW, Khan KS, Meads CA, ter Riet G. Prediction of pre-eclampsia: a protocol for systematic reviews of test accuracy. BMC Pregnancy Childbirth 2006; 6:29.
9. Spaanderman ME, Aardenburg R, Ekhart TH, van Eyndhoven HW, van der Heijden OW, van Eyck J, et al. Non-pregnant circulatory volume status predicts subsequent pregnancy outcome in normotensive thrombophilic formerly preeclamptic women. Eur J Obstet Gynecol Reprod Biol 2001; 95(2):218-221.
10. Spaanderman MEA, Aardenburg R, Ekhart THA, van Eyndhoven HWF, de Leeuw PW, Peeters LLH. Pre-pregnant prediction of recurrent preeclampsia in normotensive thrombophilic formerly preeclamptic women receiving prophylactic antithrombotic medication. J Society Gynecol Investigation 2005; 12(2):112-117.
11. Hauth J, Sibai B, Caritis S, VanDorsten P, Lindheimer M, Klebanoff M, et al. Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. Amer J Obstet Gynecol 1998; 179(5):1193-1199.
12. Caritis S, Sibai B, Hauth J, Lindheimer M, VanDorsten P, Klebanoff M, et al. Predictors of pre-eclampsia in women at high risk. Amer J Obstet Gynecol 1998; 179(4):946-951.
13. Fatini C, Sticchi E, Gensini F, Genuardi M, Tondi F, Gensini F, et al. Endothelial nitric oxide synthase gene influences the risk of pre-eclampsia, the recurrence of negative pregnancy events, and the maternal-fetal flow. J Hypertens 2006; 24(9): 1823-1829.
14. Mello G, Parretti E, Gensini F, Sticchi E, Mecacci F, Scarselli G, et al. Maternalfetal flow, negative events, and preeclampsia: role of ACE I/D polymorphism. Hypertension 2003; 41(4):932-937.
15. Trogstad LI, Eskild A, Magnus P, Samuelsen SO, Nesheim BI. Changing paternity and time since last pregnancy; the impact on pre-eclampsia risk. A study of 547 238 women with and without previous pre-eclampsia. Int J Epidemiol 2001; 30(6):1317-1322.
16. Trogstad L, Skrondal A, Stoltenberg C, Magnus P, Nesheim BI, Eskild A. Recurrence risk of preeclampsia in twin and singleton pregnancies. Am J Med Genet A 2004; 126(1):41-45.
17. Dukler D, Porath A, Bashiri A, Erez O, Mazor M. Remote prognosis of primiparous women with preeclampsia. Eur J Obstet Gynecol Reprod Biol 2001; 96(1): 69-74.
18. van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006; 195(3):723-728. (Pubitemid 44292141)
19. Hjartardottir S, Leifsson BG, Geirsson RT, Steinthorsdottir V. Recurrence of hypertensive disorder in second pregnancy. Am J Obstet Gynecol 2006; 194(4): 916-920.
20. Makkonen N, Heinonen S, Kirkinen P. Obstetric prognosis in second pregnancy after preeclampsia in first pregnancy. Hypertens Pregnan 2000; 19(2):173-181. (Pubitemid 30436484)
21. Basso O, Christensen K, Olsen J. Higher risk of pre-eclampsia after change of partner. An effect of longer interpregnancy intervals? Epidemiology 2001; 12(6): 624-629.
22. Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a populationbased Swedish cohort study. Am J Med Genet A 2004; 130(4):365-371. (Pubitemid 39441611)
23. Li DK, Wi S. Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. Am J Epidemiol 2000; 151(1):57-62. (Pubitemid 30470395)
24. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 1998; 316(7141):1343-1347. (Pubitemid 28195872)
25. Hjartardottir S, Leifsson BG, Geirsson RT, Steinthorsdottir V. Paternity change and the recurrence risk in familial hypertensive disorder in pregnancy. Hypertens Pregnancy 2004; 23(2):219-225. (Pubitemid 39096217)
26. Zhang J, Troendle JF, Levine RJ. Risks of hypertensive disorders in the second pregnancy. Paediatr Perinat Epidemiol 2001; 15(3):226-231. (Pubitemid 32737954)
27. Lopez-Llera M, Hernandez Horta JL. Pregnancy after eclampsia. Am J Obstet Gynecol 1974; 119(2):193-198.
28. Aardema MW, Lander M, Oosterhof H, De Wolf BT, Aarnoudse JG. Doppler ultrasound screening predicts recurrence of poor pregnancy outcome in subsequent pregnancies, but not the recurrence of PIH or preeclampsia. Hypertens Pregnancy 2000; 19(3):281-288.
29. Patterson RM, Gibbs CE, Wood RC. Birth weight percentile and perinatal outcome: recurrence of intrauterine growth retardation. Obstet Gynecol 1986; 68(4): 464-468. (Pubitemid 16014493)
30. Rasmussen S, Irgens LM, Albrechtsen S, Dalaker K. Predicting preeclampsia in the second pregnancy from low birth weight in the first pregnancy. Obstet Gynecol 2000; 96(5 Pt 1): -696-700.
31. Sullivan CA, Magann EF, Perry KG, Jr., Roberts WE, Blake PG, Martin JN, Jr. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am J Obstet Gynecol 1994; 171(4):940-943.
32. Campbell DM, MacGillivray I, Carr-Hill R. Pre-eclampsia in second pregnancy. Br J Obstet Gynaecol 1985; 92(2):131-140. (Pubitemid 15162717)
33. Hargood JL, Brown MA. Pregnancy-induced hypertension: recurrence rate in second pregnancies. Med J Aust 1991; 154(6):376-377.
34. Gudnasson HM, Dubiel M, Gudmundsson S. Preeclampsia-abnormal uterine artery Doppler is related to recurrence of symptoms during the next pregnancy. J Perinat Med 2004; 32(5):400-403. (Pubitemid 39304407)
35. Sibai BM, Sarinoglu C, Mercer BM. Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis. Am J Obstet Gynecol 1992; 166(6 Pt 1):1757-1761; discussion 1761-1763.
36. Brown M, Mackenzie C, Dunsmuir W, Roberts L, Ikin K, Matthews J, et al. Can we predict recurrence of pre-eclampsia or gestational hypertension? BJOG 2007; 114(8): 984-993
37. Adelusi B, Ojengbede OA. Reproductive performance after eclampsia. Int J Gynaecol Obstet 1986; 24(3):183-189.
38. Chames MC, Haddad B, Barton JR, Livingston JC, Sibai BM. Subsequent pregnancy outcome in women with a history of HELLP syndrome at at < or = 28 weeks of gestation Am J Obstet Gynecol 2003 188 (6) 1504-1507; discussion 1507-1508
39. Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995; 172(1 Pt 1):125-129.
40. Spaanderman ME, Aardenburg R, Ekhart TH, van Eyndhoven HW, de Leeuw PW, Peeters LL. Pre-pregnant prediction of recurrent preeclampsia in normotensive thrombophilic formerly preeclamptic women receiving prophylactic antithrombotic medication. J Soc Gynecol Investig 2005; 12(2):112-117.
41. Aardenburg R, Spaanderman ME, Ekhart TH, van Eijndhoven HW, van der Heijden OW, Peeters LL. Low plasma volume following pregnancy complicated by pre-eclampsia predisposes for hypertensive disease in a next pregnancy. BJOG 2003; 110(11):1001-1006. (Pubitemid 37338489)
42. Branch DW, Porter TF, Rittenhouse L, Caritis S, Sibai B, Hogg B, et al. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001; 184(5):825-832; discussion 832-834.
43. Simon P, Fauchet R, Pilorge M, Calvez C, Le Fiblec B, Cam G, et al. Association of HLA DR4 with the risk of recurrence of pregnancy hypertension. Kidney Int Suppl 1988; 25:S125-128.
44. Spaanderman MEA, Willekes C, Hoeks APG, Ekhart THA, Aardenburg R, Courtar DA, et al. Maternal nonpregnant vascular function correlates with subsequent fetal growth. Amer J Obstet Gynecol 2005; 192(2):504-512.
45. Morris J, Fay R, Ellwood D. Abnormal uterine artery waveforms in the second trimester are associated with adverse pregnancy outcome in high risk women. J Matern Fetal Investig 1998; 8(2):82-84.
46. Frusca T, Soregaroli M, Danti L, Guandalini F, Lojacono A, Scalvi L, et al. Uterine artery velocimetry as a screening test in patients with previous preeclampsia. Ital J Gynaecol Obstet 1996; 8(3):94-98.
47. Mello G, Parretti E, Cioni R, Lagozio C, Mealli F, Pratesi M. Individual longitudinal patterns in biochemical and hematological markers for the early prediction of pre-eclampsia. J Matern Fetal Neonat Med 2002; 11(2):93-99.
48. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 2008; 112(2):359-372.
49. Sibai BM, Koch MA, Freire S, Pinto e Silva JL, Rudge MV, Martins-Costa S, et al. Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia? Am J Obstet Gynecol 2008; 199(3):268 e1-9.